RENAL-FUNCTION WAS NOT IMPAIRED BY TREATMENT WITH 5-AMINOSALICYLIC ACID IN RATS AND MAN

被引：38

作者：

DIENER, U

TUCZEK, HV

FISCHER, C

MAIER, K

KLOTZ, U

机构：

[1] HOSP BAD CANNSTATT,MED CLIN,STUTTGART,FED REP GER

[2] ROBERT BOSCH GMBH,DIV CLIN CHEM,STUTTGART,FED REP GER

[3] ROBERT BOSCH GMBH,DIV PATHOL,STUTTGART,FED REP GER

[4] ROBERT BOSCH GMBH,DIV CLIN PHARMACOL,STUTTGART,FED REP GER

来源：

关键词：

D O I：

10.1007/BF00505331

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：278 / 282

页数：5

共 22 条

[1] AZADKHAN AK, 1977, LANCET, V2, P892
[2] Burchardt U, 1977, Z Med Lab Diagn, V18, P190
[3] NEPHROTOXICITY AND MOLECULAR-STRUCTURE
CALDER, IC
WILLIAMS, PJ
WOODS, RA
FUNDER, CC
GREEN, CR
HAM, KN
TANGE, JD
[J]. XENOBIOTICA, 1975, 5 (05) : 303 - 307
[4] NEPHROTOXIC LESIONS FROM 5-AMINOSALICYLIC ACID
CALDER, IC
FUNDER, CC
TANGE, JD
HAM, KN
GREEN, CR
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1972, 1 (5793): : 152 - +
[5] CAMPIERI M, 1981, LANCET, V2, P270
[6] ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE
DAS, KM
EASTWOOD, MA
MCMANUS, JPA
SIRCUS, W
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) : 491 - 495
[7] URINARY-EXCRETION OF N-ACETYL-BETA-D-GLUCOSAMINIDASE AND ALANINE AMINOPEPTIDASE IN PATIENTS RECEIVING AMIKACIN OR CIS-PLATINUM
DIENER, U
KNOLL, E
LANGER, B
RAUTENSTRAUCH, H
RATGE, D
WISSER, H
[J]. CLINICA CHIMICA ACTA, 1981, 112 (02) : 149 - 157
[8] DISPOSITION OF 5-AMINOSALICYLIC ACID, THE ACTIVE METABOLITE OF SULPHASALAZINE, IN MAN
FISCHER, C
MAIER, K
STUMPF, E
VONGAISBERG, U
KLOTZ, U
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (04) : 511 - 515
[9] SIMPLIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR 5-AMINOSALICYLIC ACID IN PLASMA AND URINE
FISCHER, C
MAIER, K
KLOTZ, U
[J]. JOURNAL OF CHROMATOGRAPHY, 1981, 225 (02): : 498 - 503
[10] FLEMING JJ, 1980, BIOMED EXPRESS, V33, P251